Skip to main content

Currently Skimming:

Appendix C: Workshop Agenda
Pages 111-120

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 111...
... This workshop is sponsored by the Cell Press, The Lancet, the National Institutes of Health, and Nature Research.
From page 112...
... Welcome and opening remarks Harvey Fineberg, Workshop Chair President Gordon and Betty Moore Foundation Highlights and related recommendations from the National Academies report on Reproducibility and Replicability in Science 9:15 a.m. Q&A with audience SESSION I CULTIVATING TRANSPARENT REPORTING IN BIOMEDICAL RESEARCH Session Objectives: • Highlight current efforts by researchers, institutions, funders, and journals to increase transparency in proposing and reporting preclinical biomedical research.
From page 113...
... • Consider the role of stakeholders in supporting a cultural shift toward transparent reporting in preclinical biomedical research. For more information on cultural barriers as sources of non-reproduc ibility, see p.
From page 114...
... that are generalizable across biomedical research domains. • Consider available tools and best practices for increased trans parent reporting that support researchers and are generalizable across biomedical research domains.
From page 115...
... An institution perspective Geeta Swamy Vice Dean for Scientific Integrity Associate Vice President for Research Duke University 12:00 p.m. A funder perspective Magali Haas Chief Executive Officer and President Cohen Veterans Bioscience 12:10 p.m.
From page 116...
... 2:00 p.m. Opening remarks by session moderator Barry Coller Physician-in-Chief, Vice President for Medical Affairs, and David Rockefeller Professor The Rockefeller University 2:10 p.m.
From page 117...
... • Should scientific societies be encouraged to de velop policies relevant to transparent reporting? SESSION IV TOWARD MINIMAL REPORTING STANDARDS FOR PART 1 PRECLINICAL BIOMEDICAL RESEARCH Session Objective: • Discuss opportunities for improving the consistency of report ing guidelines and requirements for rigor and transparency by journals, funders, and institutions across the biomedical research life cycle.
From page 118...
... Breakfast available outside the Lecture Room 8:30 a.m. Welcome and overview of day 1 Harvey Fineberg, Workshop Chair President Gordon and Betty Moore Foundation 9:00 a.m.
From page 119...
... • Suggest stakeholder actions to encourage transparent reporting and practical next steps toward establishing minimal reporting standards for preclinical biomedical research.
From page 120...
... How much information should funders request, that is, to what level of detail, in grant applications? Is it possible to obtain sufficient information about transparent reporting in grant applications without dramatic expansion of the application?


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.